Delivery Order SPE2DB22D6029-SPE2DB25FLUKM

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $25,716.82 and runs through May 1, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The $11,161.86 firm fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,690.18, is for the provision of Biktarvy 50-200-25 mg tablet, a medication used in the treatment of HIV. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the medication Biktarvy 50-200-25 mg tablet. The contract has a firm fixed price, ceiling value of $41,991.26, and a performance period ending on September 16, 2024. AmerisourceBergen has been awarded similar Indefinite Delivery Contracts (IDCs) by the DLA and Department of Justice, valued up to $999,999,999 and $750,000 respectively, to...
This is a Delivery Order federal contract award issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a delivery order for Biktarvy 50-200-25 mg tablets in quantities of 30, with a ceiling value of $119,575.96 and a completion date of July 29, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $122,164.60, is for the delivery of the HIV medication Biktarvy 50-200-25 mg tablets. The contract is a firm fixed-price delivery order with a completion date of January 31, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $77,909.69 and an ultimate completion date of December 15, 2022. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has a ceiling value of $36,443.00 and a period of performance through January 5, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,791.50 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $67,963.45 and a completion date of August 12, 2024. It is a firm-fixed-price contract, which indicates the price is predetermined and not subject to adjustment. The contract does not have a set-aside designation. AmerisourceBergen, through its extensive...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLUKM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,778.46, is for the delivery of Biktarvy 50-200-25 mg tablets for a term ending on March 10, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/6/25, 10:04 AM